IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today announced the ...

A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart ...

As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult ...

GeneDx is set for strong Q3 growth with rising exome and genome testing volumes and improving reimbursement trends. Learn why ...

President Donald Trump's White House praised the USOPC commitment to keeping biological male transgender athletes out of ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...

Equitable access to genomic testing for NSCLC patients is vital for advanced therapy access, with strategies including commercial contracts and financial assistance programs. Financial toxicity and ...

A growing number of people are getting genetic testing for breast cancer, which has become more comprehensive and ...

Through remarkable advancements in genetic testing and data-driven strategies, McCarty Family Farms are setting new standards ...

This medical services stock is nearing a buy point. It has shown tremendous profit growth over the last few quarters.

The cancer was detected because he was enrolled in a "world-leading research study" which is screening 100,000 newborn babies ...